Home Cart 0 Sign in  

[ CAS No. 15854-87-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 15854-87-2
Chemical Structure| 15854-87-2
Structure of 15854-87-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 15854-87-2 ]

Related Doc. of [ 15854-87-2 ]

Alternatived Products of [ 15854-87-2 ]

Product Details of [ 15854-87-2 ]

CAS No. :15854-87-2 MDL No. :MFCD02093937
Formula : C5H4IN Boiling Point : -
Linear Structure Formula :- InChI Key :RTLUPHDWSUGAOS-UHFFFAOYSA-N
M.W : 205.00 Pubchem ID :609492
Synonyms :

Calculated chemistry of [ 15854-87-2 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 36.95
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.48 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.56
Log Po/w (XLOGP3) : 1.51
Log Po/w (WLOGP) : 1.69
Log Po/w (MLOGP) : 1.41
Log Po/w (SILICOS-IT) : 2.47
Consensus Log Po/w : 1.73

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.7
Solubility : 0.412 mg/ml ; 0.00201 mol/l
Class : Soluble
Log S (Ali) : -1.39
Solubility : 8.37 mg/ml ; 0.0408 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.98
Solubility : 0.215 mg/ml ; 0.00105 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.58

Safety of [ 15854-87-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 15854-87-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 15854-87-2 ]
  • Downstream synthetic route of [ 15854-87-2 ]

[ 15854-87-2 ] Synthesis Path-Upstream   1~24

  • 1
  • [ 110-86-1 ]
  • [ 15854-87-2 ]
YieldReaction ConditionsOperation in experiment
50%
Stage #1: With [(THF)Li(μ-2,2,6,6-tetramethylpiperidide)(μ-tert-butyl)Zn(tert-butyl)] In tetrahydrofuran at 0℃; for 2 h; Inert atmosphere
Stage #2: With iodine In tetrahydrofuran at 0℃; for 1 h; Inert atmosphere
General procedure: [Li(TMP)Zn(tBu)2] 1 was made according to the literature procedure2 on a 0.4 mmol scale in THF solution. To this solution pypyridine (0.032 mL, 0.4 mmol) was added at 0°C and the resultant light orange reaction allowed to for 2 hours. Next the solution was quenched with I2 (508 mg, in 1 mL THF) and allowed to stir for 1 hour. A 10percent solution of Na2S2O3 was added until bleaching and the product extracted with DCM (3 x 1 mL). The combined organic extracts were dried over MgSO4 and the solvent removed under reduced pressure. The residue was purified by SiO2 chromatography using EtOAc:Heptane (20:80--->30:70) to give compound 5a as an off white solid 42mg (50percent) 1H NMR (400 MHz,CDCl3) δ ppm 7.59 - 7.86 (m, 2 H) 8.07 - 8.44 (m, 2 H).
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 36, p. 4590 - 4594
[2] Journal of Organic Chemistry, 1984, vol. 49, # 20, p. 3857 - 3859
  • 2
  • [ 504-24-5 ]
  • [ 15854-87-2 ]
Reference: [1] Organic Letters, 2007, vol. 9, # 5, p. 891 - 894
[2] Chemistry - A European Journal, 2018, vol. 24, # 55, p. 14622 - 14626
[3] Tetrahedron Letters, 2010, vol. 51, # 52, p. 6839 - 6842
[4] Journal of the Chemical Society, 1953, p. 3226,3229
[5] Synthetic Communications, 1996, vol. 26, # 19, p. 3543 - 3547
  • 3
  • [ 626-61-9 ]
  • [ 15854-87-2 ]
Reference: [1] Journal of Organic Chemistry, 2009, vol. 74, # 13, p. 4893 - 4895
[2] Monatshefte fuer Chemie, 1885, vol. 6, p. 315[3] Chemische Berichte, 1885, vol. 18, p. 930
[4] Chemical & Pharmaceutical Bulletin, 1982, vol. 30, # 5, p. 1731 - 1737
  • 4
  • [ 1120-87-2 ]
  • [ 15854-87-2 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 10, p. 1349 - 1360
  • 5
  • [ 7379-35-3 ]
  • [ 15854-87-2 ]
Reference: [1] Synlett, 2003, # 12, p. 1801 - 1804
[2] Inorganic Chemistry, 2015, vol. 54, # 12, p. 6055 - 6061
  • 6
  • [ 19524-06-2 ]
  • [ 5029-67-4 ]
  • [ 15854-87-2 ]
Reference: [1] Patent: US6358971, 2002, B1,
  • 7
  • [ 626-61-9 ]
  • [ 10034-85-2 ]
  • [ 15854-87-2 ]
Reference: [1] Monatshefte fuer Chemie, 1885, vol. 6, p. 315[2] Chemische Berichte, 1885, vol. 18, p. 930
  • 8
  • [ 15854-87-2 ]
  • [ 7037-49-2 ]
Reference: [1] Tetrahedron Letters, 2017, vol. 58, # 29, p. 2856 - 2858
  • 9
  • [ 19524-06-2 ]
  • [ 5029-67-4 ]
  • [ 15854-87-2 ]
Reference: [1] Patent: US6358971, 2002, B1,
  • 10
  • [ 15854-87-2 ]
  • [ 626-64-2 ]
Reference: [1] Chemistry - A European Journal, 2010, vol. 16, # 8, p. 2366 - 2370
[2] Tetrahedron Letters, 2011, vol. 52, # 41, p. 5338 - 5341
  • 11
  • [ 15854-87-2 ]
  • [ 108-90-7 ]
  • [ 5957-96-0 ]
  • [ 4467-15-6 ]
  • [ 5957-92-6 ]
Reference: [1] Tetrahedron Letters, 1989, vol. 30, # 26, p. 3433 - 3436
  • 12
  • [ 15854-87-2 ]
  • [ 108-95-2 ]
  • [ 4783-86-2 ]
Reference: [1] Catalysis Science and Technology, 2016, vol. 6, # 6, p. 1701 - 1709
[2] Synlett, 2012, # 1, p. 101 - 106
[3] Tetrahedron Letters, 2006, vol. 47, # 29, p. 5045 - 5048
  • 13
  • [ 15854-87-2 ]
  • [ 139-02-6 ]
  • [ 4783-86-2 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 24, p. 4931 - 4935
  • 14
  • [ 15854-87-2 ]
  • [ 100-51-6 ]
  • [ 49826-70-2 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 24, p. 4931 - 4935
  • 15
  • [ 15854-87-2 ]
  • [ 111-86-4 ]
  • [ 64690-19-3 ]
Reference: [1] Journal of the American Chemical Society, 2008, vol. 130, # 20, p. 6586 - 6596
  • 16
  • [ 188290-36-0 ]
  • [ 15854-87-2 ]
  • [ 21298-54-4 ]
  • [ 21308-82-7 ]
Reference: [1] Heterocycles, 1986, vol. 24, # 3, p. 799 - 803
  • 17
  • [ 15854-87-2 ]
  • [ 1692-15-5 ]
  • [ 1910-42-5 ]
Reference: [1] Patent: CN107935918, 2018, A,
  • 18
  • [ 2510-22-7 ]
  • [ 15854-87-2 ]
  • [ 73564-69-9 ]
Reference: [1] Chemistry - A European Journal, 2011, vol. 17, # 25, p. 7032 - 7040
[2] Tetrahedron Letters, 1999, vol. 40, # 29, p. 5413 - 5416
  • 19
  • [ 15854-87-2 ]
  • [ 133810-35-2 ]
  • [ 73564-69-9 ]
Reference: [1] Journal of the American Chemical Society, 2013, vol. 135, # 33, p. 12228 - 12240
  • 20
  • [ 15854-87-2 ]
  • [ 73564-69-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 7, p. 1879 - 1882
  • 21
  • [ 15854-87-2 ]
  • [ 73564-69-9 ]
Reference: [1] Journal of the American Chemical Society, 2013, vol. 135, # 33, p. 12228 - 12240
  • 22
  • [ 93-58-3 ]
  • [ 15854-87-2 ]
  • [ 126179-78-0 ]
  • [ 106047-17-0 ]
  • [ 106047-16-9 ]
Reference: [1] Tetrahedron Letters, 1989, vol. 30, # 26, p. 3433 - 3436
  • 23
  • [ 76-09-5 ]
  • [ 15854-87-2 ]
  • [ 181219-01-2 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 28, p. 4737 - 4740
  • 24
  • [ 15854-87-2 ]
  • [ 87199-17-5 ]
  • [ 99163-12-9 ]
Reference: [1] Chemistry - An Asian Journal, 2018, vol. 13, # 9, p. 1108 - 1113
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 15854-87-2 ]

Pyridines

Chemical Structure| 22282-65-1

[ 22282-65-1 ]

4-Iodo-2-methylpyridine

Similarity: 0.83

Chemical Structure| 105752-11-2

[ 105752-11-2 ]

3-Amino-4-iodopyridine

Similarity: 0.79

Chemical Structure| 552331-00-7

[ 552331-00-7 ]

4-Iodopyridin-2-amine

Similarity: 0.79

Chemical Structure| 1120-90-7

[ 1120-90-7 ]

3-Iodopyridine

Similarity: 0.79

Chemical Structure| 100523-96-4

[ 100523-96-4 ]

2-Bromo-4-iodopyridine

Similarity: 0.77